期刊
CURRENT MOLECULAR MEDICINE
卷 6, 期 8, 页码 905-918出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156652406779010830
关键词
notch; cancer; gamma-secretase
资金
- NCI NIH HHS [R01 CA84065] Funding Source: Medline
- NIA NIH HHS [P01AG025531] Funding Source: Medline
The evolutionary conserved developmental pathway driven by Notch receptors and ligands has acquired multiple post-natal homeostatic functions in vertebrates. Potential roles in human physiology and pathology are being studied by an increasingly large number of investigators. While the canonical Notch signaling pathway is deceptively simple, the consequences of Notch activation on cell fate are complex and context-dependent. The manner in which other signalling pathways cross-talk with Notch signalling appears to be extraorfinally complex. Recent observations have demonstrated the importance of endocytosis, multiple ubiquitin ligases, non-visual beta-arrestins and hypoxia in modulating Notch signaling. Structural biology is shedding light on the molecular mechanisms whereby Notch interacts with its nuclear partners. Genomics is slowly unraveling the puzzle of Notch target genes in several systems. At the same time, interest in modulating Notch signaling for medical purposes has dramatically increased. Over the last few years we have learned much about Notch signaling in cancer, immune disorders, neurological disorders and most recently, stroke. The role of modulating drugs are already in clinical trials, and others at various stages of development. This review will focus on the most recent findings on Notch signaling in cancer and discuss thier clinical implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据